RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: vitiligo
Accession: DOID:12306
browse the term
Definition: An autoimmune disease that causes depigmentation of patches of skin resulting from loss of function or death of melanoctyes. (DO)
Synonyms: exact_synonym: SLEV1; VTLG; vitiligo-related systemic lupus erythematosus
related_synonym: AIS1; AIS2; AIS3; AIS4; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 1p-RELATED; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 4-RELATED; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 7-RELATED; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 8-RELATED; Autoimmune Disease, Susceptibility To, 1; Autoimmune Disease, Susceptibility To, 2; Autoimmune Disease, Susceptibility To, 3; Autoimmune Disease, Susceptibility To, 4; VAMAS1; VAMAS2; VAMAS3; VAMAS4; VAMAS5; VAMAS6; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 2; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 3; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 4; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 5; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6
primary_id: MESH:D014820
alt_id: MIM:193200 ; MIM:606579 ; MIM:607836 ; MIM:608391 ; MIM:608392 ; MIM:609400
xref: EFO:0004208 ; GARD:10751 ; ICD10CM:L80 ; ICD9CM:709.01 ; NCI:C26915
For additional species annotation, visit the
Alliance of Genome Resources .
G
BACH2
BTB domain and CNC homolog 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 1:57,881,203...58,281,740
Ensembl chr 1:57,899,808...58,281,430
G
C3
complement C3
ISO
RGD
PMID:12121667
RGD:7401277
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
CASP7
caspase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr14:124,017,776...124,050,369
Ensembl chr14:124,019,164...124,050,365
G
CAT
catalase
susceptibility no_association
ISO
protein:decreased activity:skin: DNA:SNP,haplotype:promoter,cds:-89A>T,389C>T(human) DNA:SNPs:promoter,exon: -89A>T rs7943316), 389C>T (rs769217)(human)
RGD
PMID:19439879 PMID:20613769 PMID:23868633
RGD:9479149 RGD:9479150 RGD:9479169
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CCR6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20526340
NCBI chr 1:2,016,600...2,034,172
Ensembl chr 1:2,018,608...2,019,821
G
CD44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153
G
CD80
CD80 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr13:140,693,312...140,730,541
Ensembl chr13:140,693,382...140,728,976
G
CLNK
cytokine dependent hematopoietic cell linker
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 8:6,604,975...6,769,769
Ensembl chr 8:6,608,853...6,769,572
G
CLU
clusterin
ISO
RGD
PMID:7558712
RGD:8699503
NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,595...11,349,764
G
COMT
catechol-O-methyltransferase
no_association
ISO
DNA:polymorphism: :p.V158M (human)
RGD
PMID:19112571 PMID:24915010
RGD:8662333 RGD:8662336
NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility no_association
ISO
associated with Autoimmune Diseases;DNA:polymorphisms: : DNA:SNP:3'UTR:rs3087243(human) DNA:SNP:exon:+49A>G rs231775)(human) DNA:SNPs:multiple:
RGD
PMID:15649153 PMID:18200060 PMID:19129082 PMID:21794098
RGD:7411687 RGD:7411696 RGD:7411697 RGD:7411699
NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
G
ESR1
estrogen receptor 1
no_association susceptibility
ISO
DNA:SNP:exon DNA:SNP:intron
RGD
PMID:15381239
RGD:8552976
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
FOXD3
forkhead box D3
susceptibility
ISO
ClinVar Annotator: match by term: Autoimmune disease, susceptibility to, 1
OMIM ClinVar
PMID:16098053
NCBI chr 6:149,153,397...149,155,576
Ensembl chr 6:149,154,033...149,155,478
G
FOXP1
forkhead box P1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20526340
NCBI chr13:52,346,844...52,974,358
Ensembl chr13:52,348,234...52,876,892
G
HGF
hepatocyte growth factor
treatment
ISO
RGD
PMID:16117796
RGD:8548598
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
G
IFIH1
interferon induced with helicase C domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr15:68,930,998...68,985,145
Ensembl chr15:68,928,254...68,985,083
G
IFNG
interferon gamma
onset susceptibility
ISO
DNA:polymorphism:intron:rs2430561(human) DNA:repeats:intron:rs3138557(human)
RGD
PMID:23777204
RGD:8157616
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IKZF4
IKAROS family zinc finger 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 5:21,399,858...21,427,648
Ensembl chr 5:21,400,347...21,427,647
G
IL13
interleukin 13
treatment
ISO
RGD
PMID:23680073
RGD:8549591
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
G
IL17A
interleukin 17A
ISO
protein:increased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL1A
interleukin 1 alpha
ISO
protein:increased expression:skin CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16911396 PMID:28836394
RGD:7794736
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
G
IL2
interleukin 2
ISO
protein:increased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL4
interleukin 4
ISO
protein:increased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
ITK
IL2 inducible T cell kinase
ISO
ClinVar Annotator: match by term: Vitiligo-associated multiple autoimmune disease susceptibility 1
ClinVar
PMID:28492532 PMID:32628964 PMID:32888943
NCBI chr16:66,010,766...66,082,263
Ensembl chr16:66,010,772...66,082,185
G
KIF1B
kinesin family member 1B
ISO
ClinVar Annotator: match by term: Vitiligo
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 6:70,495,143...70,663,464
Ensembl chr 6:70,495,144...70,661,798
G
MBL2
mannose binding lectin 2
susceptibility no_association
ISO
DNA:polymorphism:exon: DNA:polymorphisms:promoter, exon:
RGD
PMID:17337399 PMID:19416237
RGD:8693723 RGD:8693724
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
G
MC1R
melanocortin 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 6:181,225...182,187
Ensembl chr 6:181,225...182,187
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28836394
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NLRP1
NLR family pyrin domain containing 1
susceptibility
ISO
ClinVar Annotator: match by term: Vitiligo-associated multiple autoimmune disease susceptibility 1
ClinVar OMIM
PMID:17377159 PMID:25741868 PMID:27662089 PMID:28492532
NCBI chr12:51,479,968...51,495,540
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28836394
NCBI chr16:46,434,757...46,523,626
Ensembl chr16:46,511,521...46,523,609
G
PSMB9
proteasome 20S subunit beta 9
ISO
RGD
PMID:14551602
RGD:1578358
NCBI chr 7:25,072,133...25,077,508
Ensembl chr 7:25,072,323...25,078,322
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
ISO
DNA:polymorphism: :1858C>T (p.R620W) (human) DNA: snp : cds: rs2476601
RGD
PMID:16015369 PMID:18426414
RGD:6484552 RGD:7829737
NCBI chr 4:106,692,102...106,758,101
Ensembl chr 4:106,686,604...106,758,099
G
SH2B3
SH2B adaptor protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr14:32,623,286...32,664,606
Ensembl chr14:32,623,286...32,664,606
G
SLA
Src like adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 4:8,166,829...8,247,396
Ensembl chr 4:8,189,232...8,247,388
G
SOD2
superoxide dismutase 2
disease_progression
ISO
DNA, mRNA, protein:SNPs, increased expression:cds:p.L84F (rs11575993), p.T58I (rs35289490), skin, leukocyte (human)
RGD
PMID:24036105
RGD:8547522
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
TGFB1
transforming growth factor beta 1
ISO
protein:decreased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
TLR2
toll like receptor 2
susceptibility
ISO
DNA:polymorphism:exon:p.R753Q(human)
RGD
PMID:22429552
RGD:7777152
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
TLR4
toll like receptor 4
susceptibility
ISO
DNA:polymorphism:exon:p.D299G(human)
RGD
PMID:22429552
RGD:7777152
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
TNF
tumor necrosis factor
ISO
protein:increased expression:skin CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16911396 PMID:28836394
RGD:7794736
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
G
TOB2
transducer of ERBB2, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 5:7,086,397...7,098,643
Ensembl chr 5:7,086,651...7,098,637
G
TYR
tyrosinase
severity
ISO
RGD
PMID:8697641 PMID:22834951
RGD:8694387 RGD:8694409
NCBI chr 9:22,517,047...22,604,290
Ensembl chr 9:22,517,047...22,604,290
G
VDR
vitamin D receptor
no_association
ISO
DNA:SNPs, haplotype: :multiple DNA:SNPs: :rs731236, rs1544410, rs7975232 (human) DNA:SNP:exon:rs2228570 (human)
RGD
PMID:22738935 PMID:22762534
RGD:8158061 RGD:8158066
NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,266,475
G
DSTYK
dual serine/threonine and tyrosine protein kinase
ISO
ClinVar Annotator: match by term: DSTYK-related condition | ClinVar Annotator: match by term: Hereditary spastic paraplegia 23
OMIM ClinVar
PMID:17273976 PMID:23862974 PMID:25741868 PMID:27657687 PMID:28492532 PMID:28566479 PMID:33624863 More...
NCBI chr 9:65,833,050...65,892,024
Ensembl chr 9:65,833,054...65,891,999
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all